Hypoxia and Medicine

Home > Effects Of Hypoxia Information > Effects Of Hypoxia News

Effects Of Hypoxia News

  • Soldier died of cocaine overdose Wednesday, July 6, 2011 @ 9:24AMA coroner at the inquest into the death of an Irish soldier warns witnesses who fail to turn up at inquests they could be held in contempt
  • Air Pollution Could Damage Your Brain Wednesday, July 6, 2011 @ 7:37AMYou knew it wasn't good for your lungs, but new tests find that pollution affects your cognitive abilities and may cause depression. It's no secret that breathing in polluted air on a regular basis can do a number on your heart and lungs. Now researchers from Ohio State University claim that air pollution can cause learning and memory problems, as well as depression. The research, published this ...
  • Threshold Pharmaceuticals Announces National Comprehensive Cancer Network (NCCN) Grant for Phase 1 Trial of TH-302 in ... Wednesday, July 6, 2011 @ 7:10AMREDWOOD CITY, Calif.--(BUSINESS WIRE)--Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced that The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, awarded a grant to Dr. Herb Hurwitz, Associate Professor of Medicine at the Duke Cancer Institute, to evaluate Threshold Pharmaceuticals’ hypoxia activated prodrug, TH ...
  • Marine species at risk of mass extinction Tuesday, June 21, 2011 @ 3:29AMAn unprecedented number of marine species are at risk of extinction. Increasing levels of CO2 contributes to rising temperatures. In turn, increased temperatures lead to more CO2 being absorbed into the ocean. Increased CO2 in the ocean leads to increasing ocean acidification and hypoxia, which are devastating for marine life.
  • Dead zone may set record Wednesday, June 15, 2011 @ 12:16PMHOUMA — The colossal flow from this year’s record river flooding could trigger the Gulf’s largest-ever dead zone, scientists say.
  • Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual ... Wednesday, May 18, 2011 @ 5:00PMDendreon Corporation today announced three abstracts accepted for poster presentation detailing clinical trial plans for PROVENGE® and the clinical trial of DN24-02 in bladder cancer at the upcoming American Society for Clinical Oncology annual meeting in Chicago, Illinois.
  • Link Between Obstructive Sleep Apnea And Cancer Growth In Mice Wednesday, May 18, 2011 @ 4:52AMA new study links the intermittent interruption of breathing that occurs in patients with obstructive sleep apnea (OSA) to enhanced proliferation of melanoma cancer cells and increased tumor growth in mice, according to researchers in Spain. The study also found tumor cells of OSA mouse models tended to contain more dead cells, indicating a more aggressive type of cancer. The results of the ...
  • Press Release Friday, May 6, 2011 @ 8:03AMEnzon Pharmaceuticals Inc. Posted on:06 May 11 Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the first quarter of 2011.
  • Enzon Reports 1st Quarter 2011 Results Friday, May 6, 2011 @ 7:16AMPISCATAWAY, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the first quarter of 2011. For the first quarter of 2011, Enzon reported income from continuing operations of $431 thousand, or $0.01 on a diluted per-share basis, as compared to income from continuing operations of $20.8 million, or $0.29 per diluted share for the first ...
  • High Altitude Boosts Longevity And Reduces Risk Of Dying Of Ischemic Heart Disease Saturday, March 26, 2011 @ 3:44AMIn one of the most comprehensive studies of its kind, researchers at the University of Colorado School of Medicine in partnership with the Harvard School of Global Health have found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others...
  • Living at high altitude 'cuts risk of dying from heart disease' Saturday, March 26, 2011 @ 1:52AMWashington, March 26 (ANI): A new study has found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others.
  • Living at high altitude 'cuts risk of dying from heart disease' Saturday, March 26, 2011 @ 1:30AMWashington, March 26 : A new study has found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others.
  • EPA Drafts Report on Biofuel Impacts Monday, January 31, 2011 @ 12:06PMThe EPA's National Center for Environmental Assessment has posted a draft report examining some of the impacts of biofuels, opening the report for public comment.
  • Managing soils focus of workshop Sunday, January 30, 2011 @ 8:48PMManaging Soils will be the focus of a Soil and Water Management Seminar sponsored by University of Illinois Extension Wednesday, Feb. 23. The workshop will be at the Livingston County Extension Office, 1412 S. Locust St., Pontiac. Presentations will be
  • Extension connection Saturday, January 29, 2011 @ 6:48AMWinter is a wonderful time to increase your knowledge base. Wonder how and where you can do that? Attend any of the following University of Illinois Extension events. As we transition into the Fulton-Mason-Peoria-Tazewell Extension unit, today’s article features events held in three of the four counties.
  • Press Release Monday, January 24, 2011 @ 10:31AMSpectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Thursday, January 20, 2011, it submitted a Post Approval Supplement containing data supporting the removal of the Indium-111 ZEVALIN® pre-treatment imaging evaluation, more commonly referred to as the ...
  • Threshold Pharmaceuticals' TH-302 Continues to Demonstrate Promising Activity in Pancreatic Cancer Phase 1/2 Clinical ... Monday, January 24, 2011 @ 7:25AMREDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. today announced updated Phase 1/2 clinical trial results related to the Company's clinical stage hypoxia-activated prodrug, TH-302.
  • Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN® Monday, January 24, 2011 @ 6:05AMIRVINE, Calif.--(BUSINESS WIRE)--SPECTRUM PHARMACEUTICALS SUBMITS DATA TO FDA IN SUPPORT OF BIOSCAN REMOVAL FOR ZEVALIN®
  • Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN® Monday, January 24, 2011 @ 6:00AMSpectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Thursday, January 20, 2011, it submitted a Post Approval Supplement containing data supporting the removal of the Indium-111 ZEVALIN® pre-treatment imaging evaluation, more commonly referred to as the “bioscan” requirement.
  • Comment on Mystery of mass animal death epidemic deepens by flyer168 Saturday, January 8, 2011 @ 3:39AMLKS, Just to share this with you... The 10 Leading Theories For Dead Birds And Fish Nicholas West and Zen Gardner Activist Post January 6, 2011 - http://www.infowars.com/the-10-leading-theories-for-dead-birds-and-fish/ You be the judge. Cheers.
  • Animal death mystery: Two MILLION dead fish wash up in Maryland bay Friday, January 7, 2011 @ 3:39AMResidents in Faenza described the birds falling to the ground like 'little Christmas balls' with strange blue stains on their beaks.
  • Emerging drug class may enhance red blood cell production in anemic patients Wednesday, December 22, 2010 @ 1:44PMBy determining how corticosteroids act to promote red blood cell progenitor formation, Whitehead Institute researchers have identified a class of drugs that may be beneficial in anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.
  • Emerging Drug Class May Enhance Red Blood Cell Production in Anemic Patients Wednesday, December 22, 2010 @ 1:33PMBy determining how corticosteroids act to increase production of red blood cell progenitors, Whitehead Institute researchers have identified a class of drugs that may be beneficial in treating some erythropoietin-resistant anemias. The identified class of drugs may be able to treat other anemias.
  • Emerging drug class may enhance red blood cell production in anemic patients Wednesday, December 22, 2010 @ 1:18PM( Whitehead Institute for Biomedical Research ) By determining how corticosteroids act to increase production of red blood cell progenitors, Whitehead Institute researchers have identified a class of drugs that may be beneficial in treating some erythropoietin-resistant anemias. One such anemia is Diamond-Blackfan anemia (DBA), which is frequently treated with corticosteroids, despite their ...
  • Threshold Pharmaceuticals Announces Promising Early Phase 1 Clinical Trial Results in Patients With Advanced Leukemias Wednesday, December 22, 2010 @ 7:35AMREDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. , today announced a preclinical collaboration with the MD Anderson Cancer Center and early Phase 1 clinical trial results of TH-302 in patients with advanced leukemias, which is also taking place at MD Anderson.
  • Health agency warns of U.S. whooping cough outbreak Tuesday, December 21, 2010 @ 2:08PMThe Public Health Agency of Canada is warning U.S.-bound travellers to be on guard against whooping cough, which is also known as pertussis.
  • FG-2216 drug offers new treatment for kidney disease-related anemia Tuesday, November 30, 2010 @ 4:29AMA new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
  • New approach may help dialysis patients fight anemia Monday, November 29, 2010 @ 10:11PMA new drug called FG-2216 can stimulate production of the hormone erythropoietin in dialysis patients -- possibly offering a new approach to treatment of kidney disease-related anemia, according to a new study.
  • Bacteria, the anti-cancer soldier Wednesday, November 3, 2010 @ 11:09AMEveryone knows about cancer. According to the World Health Organization eight million people died of one of the many forms of cancer 2007 and this number is expected to grow to more than 12 million by 2030. However, unlike many other significant diseases, cancer is not confined to a continent or socioeconomic cohort. Also unlike other entrants on the WHO’s top 10 there is no vaccine or wonder ...
  • Threshold Pharmaceuticals Awarded $488,958 in Grants Under Qualifying Therapeutic Discovery Project Program Wednesday, November 3, 2010 @ 8:00AMREDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. , today announced that the Company has been awarded a total of $488,958 in grants under the Qualifying Therapeutic Discovery Project program to advance the development of clinical programs for TH-302, the Company's hypoxia activated prodrug.
  • Threshold Pharmaceuticals Presents Follow-Up Data From a Phase 1/2 Clinical Trial of TH-302 in Solid Tumors Tuesday, October 12, 2010 @ 7:30AMREDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. today announced interim results from an ongoing Phase 1/2 clinical trial in various solid tumors related to its hypoxia-activated prodrug, TH-302.
  • ESC Press Statement: Paper Highlights Need For New Studies And Guidelines Around Oxygen Therapy During MI Tuesday, September 21, 2010 @ 9:14PM“The upcoming ESC Clinical Practice Guidelines for the management of STEMI, to be published in 2012 will address this issue on the basis of the Cochrane review and the entire literature,” said Gabriel Steg from Hôpital Bichat (Paris, France), co-chairman of the ESC Task Force on the management of AMI-STEMI. Supplemental oxygen therapy, said Stefan James, also co-chairman of the ESC AMI-STEMI ...
  • High Altitude Suicide Risk? Thursday, September 16, 2010 @ 6:12AMProvocative new research suggests high altitude is in some way related to suicide risk. The assertion is challenging as the mountainous West is renowned for the beauty of its towering mountains and high deserts. Perry F. Renshaw, M.D., Ph.D., MBA, professor of psychiatry at the University of Utah School of Medicine and colleagues, report that the [...]
  • Deepak Chopra: End-of-Life Brain Activity - A Sign of the Soul? Monday, August 16, 2010 @ 8:09PMBy Stuart Hameroff, MD and Deepak Chopra, MD The idea that conscious awareness can exist after death, generally referred to as the 'soul', has...
  • Science secures Hillary's triumph Monday, August 9, 2010 @ 4:30PMScientists have established with near certainty that Sir Edmund Hillary and Tenzing Norgay were the first to reach the peak of Mt Everest after a study revealed that British adventurers George Mallory and Andrew Irvine probably did not make it in 1924.
  • Everest's biggest mystery solved Sunday, August 8, 2010 @ 11:56PMToronto, Aug 9 : The greatest mystery in mountain climbing involving the death of two British mountaineers who might have climbed Mount Everest in 1924, nearly 30 years before Edmund Hillary and Tenzing Norgay reached the world's highest summit, has been solved, claim Canadian and Indian researchers.
  • Earth Talk Wednesday, July 21, 2010 @ 2:40PMDear EarthTalk: Is it true that the BP oil leak is much more of an environmental threat than previous spills from tankers, and if so why?
  • Threshold Pharmaceuticals Presents Preclinical Results in Two Scientific Presentations at AACR Translational Cancer ... Monday, July 12, 2010 @ 3:00PMREDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. , today announced two preclinical presentations on its clinical stage hypoxia-activated prodrug, TH-302, at the American Association for Cancer Research Translational Cancer Medicine Meeting, being held July 11 to 14, 2010, in San Francisco, CA.
  • NOAA-supported scientists predict 'larger than average' Gulf dead zone Tuesday, June 29, 2010 @ 10:32AM( NOAA Headquarters ) The northern Gulf of Mexico hypoxic zone, an underwater area with little or no oxygen known commonly as the "dead zone," could be larger than the recent average, according to a forecast by a team of NOAA-supported scientists from the Louisiana Universities Marine Consortium, Louisiana State University and the University of Michigan.
  • Threshold Pharmaceuticals commences TH-302 Phase 1 clinical trial in patients with advanced leukemias Tuesday, June 29, 2010 @ 9:08AMThreshold Pharmaceuticals, Inc., today announced that it has initiated a Phase 1 clinical trial of TH-302 in patients with advanced leukemias. TH-302 is a proprietary Hypoxia-Activated Prodrug (HAP) that specifically targets tumor hypoxia.
  • Elevation of Smurf1 may play a role in molecular basis of PAH: Study Tuesday, June 22, 2010 @ 3:52AMPulmonary arterial hypertension (PAH) is a progressive disease, marked by shortness of breath and fatigue which can be fatal if untreated. Increased pressure in the pulmonary artery and its branches is associated with dysfunctional growth control of endothelial and smooth muscle cells leading to excessive thickening of the blood vessel wall, obliteration of the lumen and right heart failure.
  • Oil spill research postponed until $5 million arrives Monday, June 21, 2010 @ 10:13PMBy: Catherine Threlkeld Three universities to receive funding In addition to paying for lost wages and coastal restoration, BP will also be paying three universities to research the effects of the Deepwater Horizon oil spill. BP announced a $500 million commitment to the Gulf of Mexico Research Initiative, which ...
  • New link between air pollution, sleep-disordered breathing Tuesday, June 15, 2010 @ 6:06AMScientists have established a new link between air pollution and sleep disordered breathing.
  • New link between air pollution, sleep-disordered breathing Tuesday, June 15, 2010 @ 5:17AMWashington, June 15 : Scientists have established a new link between air pollution and sleep disordered breathing.
  • Researchers establish link between air pollution and SDB Tuesday, June 15, 2010 @ 12:15AMResearchers from Brigham and Women's Hospital and the Harvard School of Public Health have established the first link between air pollution and sleep-disordered breathing, a known cause of cardiovascular diseases.
  • Oncothyreon announces presentation of Phase 1 data for PX-866 and PX-478 at American Society of Clinical Oncology ... Monday, June 7, 2010 @ 11:16AMDESCRIBES PHASE 2 DEVELOPMENT PLANS FOR PX-866 SEATTLE, WA, June 7 /PRNewswire-FirstCall/ - Oncothyreon Inc.
  • Gulf Oil Spill Could Widen 'Dead Zone’ Monday, June 7, 2010 @ 10:35AMImage Caption: A NASA satellite image recorded May 24 showing areas of oil approaching the Mississippi River delta, shown in false color to improve contrast.
  • Threshold Pharmaceuticals Presents Promising Clinical Trial Results Demonstrating Broad Anti-Tumor Activity Monday, June 7, 2010 @ 8:00AMREDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. today announced results from Phase 1/2 clinical trials in various solid tumors related to its hypoxia-activated prodrug, TH-302.
  • Oncothyreon announces presentation of Phase 1 data for PX-866 and PX-478 at American Society of Clinical Oncology ... Monday, June 7, 2010 @ 8:00AM866
  • Oil spill mysteries Tuesday, June 1, 2010 @ 11:00AMNEW ORLEANS (AP) — Independent scientists and government officials say there's a disaster we can't see in the Gulf of Mexico's mysterious depths, the ruin of a world inhabited by enormous sperm whales and tiny, invisible plankton. Researchers have...